Sep 14, 2018

FDA clears deep transcranial magnetic stimulation device to treat obsessive-compulsive disorder

Posted by in categories: biotech/medical, neuroscience

Promising approach to deliver personalized and non-invasive brain stimulation in clinical settings.

BrainsWay’s Brain Stimulation Device Receives FDA Approval to Treat Obsessive-Compulsive Disorder (IEEE Spectrum):

In 2013, Jerusalem-based BrainsWay began marketing a new type of brain stimulation device that uses magnetic pulses to treat major depressive disorder.

Now, thanks to positive results in a study of 100 patients, the company has received approval from the U.S. Food and Drug Administration (FDA) to market the device for a second psychiatric condition—obsessive-compulsive disorder (OCD) …

Read more

Comments are closed.